HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Lathrop Selected Research

Elements

1/2018Consequences of VHL Loss on Global DNA Methylome.
6/2010C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S-independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark Lathrop Research Topics

Disease

18Asthma (Bronchial Asthma)
10/2019 - 12/2004
14Neoplasms (Cancer)
01/2023 - 08/2007
8Coronary Disease (Coronary Heart Disease)
02/2012 - 03/2002
7Type 2 Diabetes Mellitus (MODY)
10/2023 - 06/2007
7Breast Neoplasms (Breast Cancer)
05/2018 - 06/2010
6Myocardial Infarction
02/2019 - 02/2003
6Thrombophilia
01/2012 - 03/2003
5Alzheimer Disease (Alzheimer's Disease)
11/2023 - 06/2005
5Kidney Neoplasms (Kidney Cancer)
06/2021 - 10/2011
5Insulin Resistance
01/2020 - 07/2004
5Inflammation (Inflammations)
01/2019 - 04/2008
5Stroke (Strokes)
01/2018 - 06/2005
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2023 - 12/2009
4Cerebral Malaria
01/2020 - 01/2012
4Melanoma (Melanoma, Malignant)
11/2016 - 10/2011
4Prostatic Neoplasms (Prostate Cancer)
10/2016 - 04/2013
4Venous Thrombosis (Deep-Vein Thrombosis)
04/2012 - 06/2005
4Ichthyosis (Xeroderma)
01/2012 - 03/2006
4Cardiovascular Diseases (Cardiovascular Disease)
08/2011 - 02/2003
3Renal Cell Carcinoma (Grawitz Tumor)
01/2023 - 01/2018
3Aortic Valve Stenosis (Aortic Stenosis)
01/2020 - 01/2017
3Infections
01/2020 - 08/2010
3Neuroinflammatory Diseases
01/2020 - 11/2016
3Macular Degeneration (Age-Related Maculopathy)
11/2014 - 02/2012
3Essential Hypertension
01/2013 - 11/2002
3Hypertension (High Blood Pressure)
01/2013 - 03/2006
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2012 - 04/2007
3Lung Neoplasms (Lung Cancer)
04/2010 - 04/2008
3Sickle Cell Anemia (Hemoglobin S Disease)
10/2009 - 07/2007
3beta-Thalassemia (Cooley's Anemia)
10/2009 - 07/2007
3Acquired Immunodeficiency Syndrome (AIDS)
12/2006 - 09/2005
3Thrombosis (Thrombus)
01/2006 - 03/2002
2Vascular Diseases (Vascular Disease)
01/2020 - 02/2011
2Muscular Diseases (Myopathy)
01/2020 - 01/2007
2Glucose Intolerance
01/2020 - 01/2019
2Coronary Stenosis (Coronary Artery Stenosis)
02/2019 - 01/2012
2Atherosclerosis
02/2019 - 07/2006
2Hypoxia (Hypoxemia)
01/2018 - 10/2011
2Carcinogenesis
01/2018 - 10/2011
2Rhinitis
01/2016 - 09/2014
2Obesity
08/2015 - 09/2007
2Bipolar Disorder (Manic Depressive Psychosis)
01/2014 - 03/2011
2Psoriasis (Pustulosis Palmaris et Plantaris)
02/2012 - 11/2009
2Alcoholism (Alcohol Abuse)
06/2011 - 07/2008
2Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2007 - 07/2004
2Diabetic Nephropathies (Diabetic Nephropathy)
04/2007 - 11/2006
1Cognitive Dysfunction
11/2023
1Genetic Risk Score
01/2023
1Disease Susceptibility (Diathesis)
11/2022
1Emphysema
11/2021

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
11/2023 - 04/2003
6Insulin (Novolin)FDA Link
01/2018 - 09/2007
6DNA (Deoxyribonucleic Acid)IBA
01/2017 - 08/2007
5LipidsIBA
10/2023 - 10/2004
5SmokeIBA
10/2019 - 11/2008
4Biomarkers (Surrogate Marker)IBA
11/2023 - 02/2012
4ApolipoproteinsIBA
01/2023 - 02/2003
4CytokinesIBA
11/2021 - 07/2006
4Glucose (Dextrose)FDA LinkGeneric
01/2020 - 06/2007
4Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA
01/2020 - 01/2012
4Protein CIBA
01/2018 - 07/2004
4Vitamin DFDA LinkGeneric
01/2017 - 04/2008
4EnzymesIBA
01/2017 - 03/2006
3Protein Isoforms (Isoforms)IBA
01/2018 - 06/2010
3Lipoprotein(a)IBA
01/2018 - 02/2011
3Immunoglobulin E (IgE)IBA
01/2017 - 12/2004
3Peptides (Polypeptides)IBA
10/2016 - 10/2009
3Prostate-Specific Antigen (Semenogelase)IBA
02/2015 - 04/2013
3AllergensIBA
11/2014 - 12/2004
3P-2 (P 2)IBA
09/2014 - 11/2008
3Estrogen ReceptorsIBA
12/2012 - 07/2010
3Protein SIBA
04/2012 - 06/2010
3Apolipoproteins E (ApoE)IBA
01/2010 - 02/2003
3Fetal Hemoglobin (Hemoglobin F)IBA
10/2009 - 07/2007
2CalciumIBA
01/2023 - 11/2021
2Triglycerides (Triacylglycerol)IBA
01/2023 - 01/2020
2Adenylyl Cyclases (Adenylyl Cyclase)IBA
11/2021 - 06/2011
2Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
11/2021 - 04/2008
2Troleandomycin (TAO)FDA Link
10/2019 - 10/2016
2Lipoproteins (Lipoprotein)IBA
02/2019 - 12/2009
2Endothelial Protein C ReceptorIBA
01/2018 - 01/2011
2ElementsIBA
01/2018 - 06/2010
2Transcription Factors (Transcription Factor)IBA
01/2018 - 10/2009
2Interferon Type IIBA
01/2017 - 11/2016
2Interleukin-33IBA
10/2016 - 09/2010
2Carrier Proteins (Binding Protein)IBA
10/2016 - 10/2016
2NucleotidesIBA
10/2016 - 07/2004
2hydroxide ionIBA
02/2015 - 04/2013
2HLA-DQ Antigens (HLA-DQ)IBA
11/2014 - 09/2010
2Glycoproteins (Glycoprotein)IBA
11/2014 - 10/2011
2Phosphatidylinositols (Phosphatidylinositol)IBA
01/2014 - 02/2008
2Lipase (Acid Lipase)FDA Link
09/2012 - 01/2007
2Complement Factor H (Factor H)IBA
09/2012 - 02/2012
2HomocysteineIBA
02/2012 - 06/2005
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2012 - 09/2007
2Microphthalmia-Associated Transcription FactorIBA
10/2011 - 10/2011
2Factor VIII (Coagulation Factor VIII)IBA
08/2011 - 01/2003
2CarcinogensIBA
04/2010 - 04/2008
2Fibrinogen (Factor I)FDA Link
08/2006 - 06/2005

Therapy/Procedure

6Therapeutics
01/2023 - 04/2010